PLCL1 and cancer: Our results demonstrate that the introduction of Prip1 into MCF-7 and BT-549 cells inhibits cancer cell migration and membrane extension, and this action was required for PRIP binding to PI(4,5)P2 via the PH domain (Figs 1 and 3).